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Impacts
• Camels are at risk of exposure to C. burnetti in Laikipia County, Kenya.
• Older camels are significantly more likely to be C. burnetii seropositive.
• Camels are carriers of C. burnetii in Laikipia County, Kenya, and have the
potential to be involved in the epidemiology and transmission of these
pathogens to humans, other livestock and wildlife in the region.
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Summary
Dromedary camels (Camelus dromedarius) are an important protein source
for people in semi-arid and arid regions of Africa. In Kenya, camel popula-
tions have grown dramatically in the past few decades resulting in the poten-
tial for increased disease transmission between humans and camels. An
estimated four million Kenyans drink unpasteurized camel milk, which poses
a disease risk. We evaluated the seroprevalence of a significant zoonotic
pathogen, Coxiella burnetii (Q fever), among 334 camels from nine herds in
Laikipia County, Kenya. Serum testing revealed 18.6% positive seroprevalence
of Coxiella burnetii (n = 344). Increasing camel age was positively associated
with C. burnetii seroprevalence (OR = 5.36). Our study confirmed that
camels living in Laikipia County, Kenya, have been exposed to the zoonotic
pathogen, C. burnetii. Further research to evaluate the role of camels in dis-
ease transmission to other livestock, wildlife and humans in Kenya should be
conducted.
Introduction
Dromedary camels (Camelus dromedarius) are an impor-
tant protein source for people in semi-arid and arid regions
of Africa. In Kenya, camel populations have increased dra-
matically in the past few decades with estimates of 717,500
camels in 2000 increasing to 2.9 million in 2013 (FAO
2016). During this period, camel milk production in Kenya
rose from 335,000 tons to 937,000 tons, and meat produc-
tion from 15,000 tons to 651 000 tons (FAO 2016). Kenyan
land use for milk production has increased for camels at a
time when land use for cattle ranching concurrently
decreased by half (Bosire et al., 2015). Camels in Kenya are
used primarily for milk production, with a shift from sub-
sistence to market production having increased signifi-
cantly in the last decade (Musinga et al., 2008; Hussein
Abdi, 2010; Anderson et al., 2012; Noor et al., 2013).
Increasing drought events due to climate change have led
to significant negative impacts on Kenyan livelihoods.
Because camels survive better than cattle during periods of
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food and water scarcity, many Kenyans have switched from
cattle to camels as a source of animal protein (Awuor et al.,
2009). A recent study found that 71.5% of households
interviewed in Isiolo County, northern Kenya, preferred
camels over other livestock and cited camel endurance to
climate factors as the main benefit (Kagunyu and Wanjohi,
2014).
Veterinary care and biosecurity controls for camels in
Kenya lag behind those for more traditional livestock (e.g.
cattle, sheep, goats) and may result in losses of productivity
due to disease-associated morbidity and mortality, as well
as a potential escalation of disease transmission between
camels, other livestock, wildlife and humans. Dromedary
camels have been shown to harbour agents with zoonotic
potential (e.g. Coxiella burnetii, Brucella spp., Toxoplasma
gondii, rift valley fever, anthrax) and/or those that may be
transmitted between camels, other livestock and wildlife (e.g.
blue tongue, bovine diarrhoea virus, anthrax, Trypanosoma
evansi) (Davies et al., 1985; Mustafa, 1987; Afzal and Sakkir,
1994; Al-Ani et al., 1998; OIE 2010; El-Harrak et al., 2011).
Losses due to infectious disease in camels also impact the
economies of local camel herders (Rich and Perry, 2011).
Understanding which diseases are present in camels in Kenya
is crucial for mitigating the impacts of these diseases on camel
productivity and public health. For example, Kaindi (2009)
estimated that 10% of Kenya’s 40 million people drink unpas-
teurized camel milk, and since raw milk is a possible transmis-
sion route for C. burnetii, the consumption of unpasteurized
camel milk in Kenya may pose a high public health cost in
country (Cerf and Condron, 2006; Rahimi et al., 2011; Kaindi
et al., 2012; Hussein et al., 2014; Osoro et al., 2015).
Vanderburg et al. (2014) found that contact with camels
was associated with human Q fever across Africa. In Chad,
a serosurvey of pastoralists and their livestock found that
camel breeders had a nine times higher risk of being
C. burnetii seropositive compared to the general public
(Schelling et al., 2003). In Kenya, knowledge of Q fever is
lacking although two studies found a 26.8% and 30.6%
seroprevalence among humans tested for C. burnetii anti-
bodies (Knobel et al., 2013; Mwololo et al., 2015). More
recent research revealed that 16.2% of febrile patients
admitted to hospitals in Northeastern Kenya were suffering
from acute Q fever (Njeru et al., 2016).
A pilot study in 2012 found a high C. burnetii (Q fever)
seroprevalence (30%) in one herd in Laikipia county,
Kenya (S.L. Deem, M. Kinnaird, A.S. Browne, E.M. Fevre,
unpublished results). Other research on the same herd in
2011 revealed 46% seroprevalence in adult camels at the
Mpala ranch (Depuy et al., 2014). Therefore, we focused
on this pathogen in a cross-sectional study of many camel
herds in the region. The objective of our study was to deter-
mine the seroprevalence of C. burnetii (Q fever) in dro-
medary camels of Laikipia County, Kenya. Additionally, we
sought to determine whether exposure to this pathogen
was associated with land management systems, camel
demographics or physiological abnormalities in dromedary
camels.
Materials and Methods
Study area
This study was conducted in Laikipia County, Kenya, a
10,000 km² area classified as semi-arid (Fig. 1) (Pratt and
Gwynne, 1977). This region is considered one of the most
important wildlife areas in Kenya based on wildlife abun-
dance and diversity (Georgiadis et al., 2007; Kinnaird and
O’Brien, 2012). Properties are managed as commercial live-
stock ranches, pastoralist communal land and wildlife con-
servancies; however, most properties utilize a mixed
management regime (Kinnaird and O’Brien, 2012). Camels
in the region are kept for milk and meat production, as well
as for transportation of supplies and people.
Camel sampling
We sampled camels from nine Laikipia properties under
different management regimes: five at predominantly
commercial ranching properties (i.e. camel milk produced
for sale), two at group properties (i.e. mixed commercial/
pastoralist herds for camel milk production primarily for
subsistence use) and two nomadic herds (i.e. camels used
for the movement of supplies and people). Sampling took
place from June to August 2013 and has been described
elsewhere (Deem et al., 2015).
While efforts were made to sample a diverse subset of
each population by selecting a range of ages and both sexes
from animals distributed throughout the herd, a truly ran-
dom sample was not fulfilled due to logistical constraints.
Camels were marked with paint to prevent repeat sampling
of individuals. Herders manually restrained camels by hob-
bling one front leg with a rope, so the camel could not kick
or walk away, and manually restraining the head. A 4–8 ml
blood sample was collected from the jugular vein using an
18-gauge needle and placed into serum separator and
EDTA vacutainer tubes.
We visually estimated tick load by examining the
groin, axilla, perineum and ears. Tick load was quanti-
fied per individual into four distinct ranges: no ticks, 1–
20 ticks, 21–100 ticks and >100 ticks. A veterinarian
visually determined the body condition score of each
camel as thin, normal or obese, using the visual appear-
ance of the ribs and pelvis. Ages were assigned as: young
(<6 months), juvenile (6 months to 2 years) and adult
(>2 years) based on dental wear, physical attributes and
herder/owner knowledge.
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Laboratory testing
Blood samples from the field were transported on ice to the
Mpala Research Centre. Whole blood from EDTA tubes
was used to determine packed cell volume (PCV) and total
solids (TS). PCV was evaluated using a PCV card, while TS
was determined using a refractometer; both as previously
described (Deem et al., 2011).
Blood samples from serum separator tubes were allowed
to clot and then centrifuged within 8 h of collection. Sera
were then decanted and aliquots placed in cryotubes and
stored at 20°C at the Mpala Research Centre until trans-
ported to the International Livestock Research Institute
(ILRI) in Nairobi, Kenya. Sera samples were tested at ILRI
for the presence of C. burnetii antibodies using the CHE-
KIT Q fever by IDEXX C. burnetii antibody test kit (IDEXX
Europe B.V., Scoripius 60 Building F, Hoofddorp 2132 LR,
The Netherlands) according to manufacturer’s instructions.
The CHEKIT Q fever test kit designates samples as nega-
tive, suspicious or positive, and the manufacturer reports a
sensitivity and specificity of 100% (Idexx Laboratories
2011).
Statistical analysis
We performed statistical analyses using R Version 3.2.1 (R
Core Team 2015). For a seropositive result, we evaluated
the following exposure variables: herd, age group, sex, body
condition, PCV, TS, tick score and management. We used
the ‘dplyr’ package to perform univariate analysis, with a
Student’s t-test to test continuous variables, and Fisher’s
test for categorical variables (Wickham and Francois,
2015). We used the ‘lme4’ package to perform linear
mixed-effects modelling, with ‘herd’ as a random factor
(Bates et al., 2014). A preliminary model was generated by
stepwise backward elimination of the least significant vari-
ables, and eliminated variables were assessed for confound-
ing. Confounding variables, determined by a change of
>30% in other variable coefficients, were kept in the model
even if they were non-significant. Intraclass cluster
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correlation (q) was calculated for C. burnetii seropositive
camels within herds using the ‘aod’ package with a
Monte Carlo one-way generalized linear mixed model
(Lesnoff and Lancelot, 2012). This statistical method
gives an indication of the likelihood of other animals
being positive if there is one positive animal in the
herd. A verbal description of the strength of correlation
is as follows: 0.00–0.19: ‘very weak’; 0.20–0.39: ‘weak’;
0.40–0.59: ‘moderate’; 0.60–0.79: ‘strong’; and 0.80–1.0:
‘very strong’. Suspicious results for the CHEKIT Q
fever test were counted as negative. A P value ≤0.05
was considered significant for all analyses.
Ethical approval
Approval for the study was obtained from the Kenyan
National Council of Science and Technology (NCST;
permit number NCST/RRI/12/1/BS011/064) and the
Institutional Animal and Care and Use Committee of
the Saint Louis Zoo. Oral consent was obtained from
camel owners.
Results
We sampled 334 camels from nine herds (Table 1). All nine
herds had at least two animals seropositive for C. burnetii
(Table 2).
Based on an intraclass cluster correlation (q) of 0.11,
there was noted a very weak cluster correlation. Univariate
analysis of exposure variables revealed that herd, age group
and TS were significantly associated with C. burnetii seroposi-
tivity (Table 3). Older age group and increased TS were
associated with seropositivity for C. burnetii.
The final linear mixed model for C. burnetii seropreva-
lence was generated with ‘age group’ as a significant factor
(Table 4). The serostatus of Q fever among the three age
groups is as follows: 7% young (n = 56), 14% juvenile
(n = 81) and 24% adult (n = 197).
Discussion
Our study confirmed seroprevalence of C. burnetii among
camels in Laikipia County, Kenya. Of the camels sampled,
18.6% were seropositive for C. burnetii. All nine herds had
at least two C. burnetii seropositive camels. Odds of
seropositivity among adult camels were 5.4 times the odds
of exposure in young camels. Intraclass cluster correlation
for seropositive C. burnetii camels was very weak among
herds, indicating that the presence of a seropositive animal
in a herd did not support that other camels were
Table 1. Herd size, management type and proportion of camels sam-
pled in nine camel herds in Laikipia County, Kenya
Camel herd and
management type Herd size (n)
Proportion of
camels sampled %
Commercial 1 50 75
Commercial 2 357 10
Commercial 3 50 100
Commercial 4 131 21
Commercial 5 167 36
Group 1 76 46
Group 2 18 100
Nomadic 1 34 80
Nomadic 2 122 39
Total counts 1005 33
Table 2. Prevalence of C. burnetii in camels sampled in Laikipia
County, Kenya (n = 334)
Herd (n camels sampled)
n positive for
C. burnetii (%)
Commercial 1 (34) 4 (12%)
Commercial 2 (35) 4 (11%)
Commercial 3 (50) 2 (4%)
Commercial 4 (28) 8 (29%)
Commercial 5 (60) 21 (35%)
Group 1 (35) 3 (9%)
Group 2 (18) 4 (22%)
Nomadic 1 (27) 12 (44%)
Nomadic 2 (47) 4 (9%)
All herds (334) 62 (19%)
Table 3. P-values of univariate analysis of factors related to positive
C. burnetii (Q fever) seroprevalence among camels in Laikipia County,
Kenya (n = 334)
Factor P-value
Herd <0.0001*
Sex 0.56
Ticks 0.26
Tick score 0.28
Management 0.53
Body condition score 0.30
Pack cell volume (PCV) 0.74
Total solids (TS) 0.005*
Age group 0.005*
*Significant at P ≤ 0.05
Table 4. Linear mixed-effects model for C. burnetii (Q fever) sero-
prevalence among dromedary camels
Variable Odds ratio 95% CI Pr (>|z|)
Intercept 0.042 0.012, 0.14 0.006
Juvenile age group 2.89 0.84, 10.0 0.164
Adult age group 5.36 2.09, 21.0 0.014
Herd as a random factor variance: 0.65
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seropositive in that herd. This would suggest that C. burnetii
is not highly infectious between camels in the same herd.
The ‘Commercial 5’ herd, which was sampled in both a
pilot study (S.L. Deem, M. Kinnaird, A.S. Browne, E.M.
Fevre, unpublished results), and another published study
(Depuy et al., 2014), revealed little change in seropreva-
lence over three years. This herd had the second highest
seroprevalence of the nine camel herds sampled, but expo-
sure was detected in all nine herds. Previous research in
Kenya established seroprevalence of Q fever among dogs,
cattle, sheep, goats and camels (Knobel et al., 2013; Depuy
et al., 2014). In Saudi Arabia, seroprevalence among camels
was found to be as high as 51.6% (Hussein et al., 2014).
Our results for camels in Laikipia County, Kenya are simi-
lar to studies from Iran where seroprevalence ranged from
10.7% to 28.7% (Doosti et al., 2014; Pirouz et al., 2015).
In our study, positive C. burnetii seroprevalence signifi-
cantly increased with camel age; a finding consistent with
studies from Saudi Arabia and Iran (Hussein et al., 2014;
Pirouz et al., 2015), as well as a previous study in Laikipia
County, Kenya (Depuy et al., 2014). Camels can shed and
transmit C. burnetii during parturition, and therefore we
would have expected a higher prevalence among young and
juvenile camels if transmission at birth were a significant
pathway of infection. All camels in this study, even those
near parturition, were kept in small enclosures (bomas) at
night to avoid predation; therefore, all animals in the herd
have close contact with birth fluids. If fluids associated with
parturition were a significant transmission route for Q fever
within camel herds, we would expect a uniform seropreva-
lence across the entire herd. Instead, our results suggest that
this mode of transmission is low and that camels are more
likely exposed as they age. One possible explanation for this
increased prevalence with age could be due to tick exposure
in the environment. Tick infestation was not significantly
associated with positive seroprevalence in our study, but this
may be due to the small sample size or the non-probabilistic
sampling.
A recent study in Kenya testing ticks removed from dogs
found 50% of the ticks were positive for C. burnetii using
real-time polymerase chain reaction (RT-PCR) testing
(Knobel et al., 2013). In a 2012 study of of the ‘Commercial
5’ camel herd in Laikipia County, Kenya, we tested ticks
removed from C. burnetii seropositive camels and found
high concentrations of C. burnetii via RT-PCR (S.L. Deem,
M. Kinnaird, A.S. Browne, E.M. Fevre, unpublished
results). While tick prophylaxis was used by all herd owners
in our study, applied at a minimum frequency of monthly
intervals, we still found over 56% (188/334) of camels had
ticks present on their bodies at the time of sampling.
Camels in Laikipia County, Kenya travel across the land-
scape daily to browse, which may increase their exposure to
ticks.
Previous research on one camel herd that was sampled
for this study, ‘Commercial 5’, found that camels travelled
an average of 2.2 km a day (O’Connor et al., 2015). Camel
bomas or enclosures are typically relocated every few
months to allow for new foraging areas to be accessed,
which further increases tick exposure for camels while
browsing in new environments. Acaricide use on cattle has
been found to reduce the population of adult and nymphal
host seeking ticks that feed on cattle and wildlife; therefore,
continued acaricide use in camels could reduce Q fever
transmission to wildlife in the area (Keesing et al., 2013).
The presence of C. burnetii seropositive camels in Laikipia
County, Kenya, suggests that camels may play a role in the
C. burnetii livestock reservoir, tick vector, wildlife cycle in
the area.
One limitation of our study is that we evaluated antibod-
ies to C. burnetii and not antigens. Therefore, these data
support a high level of exposure in the camels in Laikipia
County, Kenya, but we cannot state the prevalence of infec-
tion within these herds.
Contact with camels and the consumption of unpasteur-
ized camel milk may pose a public health risk in Kenya. We
strongly support the use of heat treatment for camel milk to
prevent transmission of C. burnetii and other zoonotic
pathogens from camels to humans. Efforts should be made
on a local, regional and national level to educate consumers
and camel owners about mitigating the risk of this pathogen.
Recent research in Northeastern Kenya revealed that 16.2%
of febrile patients admitted to remote hospitals suffered from
acute Q fever infection, but Q fever was not suspected by
any of the treating physicians and 99.5% of the febrile
patients had no knowledge of Q fever (Njeru et al., 2016).
Studies of infectious diseases of camels in Kenya are
needed to identify the links that camel health may have on
the health of other domestic livestock, wildlife species and
human health. We recommend that studies on camel
pathogens should occur alongside those that look at the
incidence of these infections in humans that work with
camels and/or consume camel products. The recent discov-
ery of MERS-CoV in Kenyan dromedary camels has helped
to highlight the zoonotic potential this growing industry
poses to the people of Kenya (Corman et al., 2014; Deem
et al., 2015). It is imperative that scientific research, veteri-
nary medical care and public policy for camel production
be advanced in Kenya to help mitigate public health risks
and disease transmission to sympatric wildlife and live-
stock, while advancing camel productivity in the region.
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